[Drugs and the eye].
Guerzider
V
V
Service d'ophtalmologie, Hôpital général, Dijon.
Bron
A
A
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000962:Antimalarials / Q000009:adverse effects; D002319:Cardiovascular System / Q000187:drug effects; D002386:Cataract / Q000139:chemically induced / Q000175:diagnosis; D002648:Child; D064420:Drug-Related Side Effects and Adverse Reactions; D005123:Eye / Q000187:drug effects*; D005128:Eye Diseases / Q000139:chemically induced*; D005451:Fluorescein Angiography; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D008075:Lipoproteins, HDL / Q000097:blood; D008266:Macula Lutea / Q000187:drug effects; D009798:Ocular Hypertension / Q000139:chemically induced; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D010276:Parasympatholytics / Q000009:adverse effects; D012137:Respiratory System / Q000187:drug effects; D012164:Retinal Diseases / Q000139:chemically induced / Q000175:diagnosis; D012867:Skin / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D008075:Lipoproteins, HDL; D009883:Ophthalmic Solutions; D010276:Parasympatholytics